Early in the COVID-19 pandemic, models predicted hundreds of thousands of additional TB
deaths as a result of health service disruption. To date, empirical evidence on the effects of …

Tuberculosis has affected humankind for thousands of years, but a deeper understanding of
its cause and transmission only arose after Robert Koch discovered Mycobacterium …

The COVID-19 pandemic has caused widespread disruptions to tuberculosis (TB) care and
service delivery in 2020, setting back progress in the fight against TB by several years. As …

Non-pharmaceutical interventions during the roll out of covid-19 vaccines Page 1 the bmj |
BMJ 2021;375:n2314 | doi: 10.1136/bmj.n2314 1 CHINA’S RESPONSE TO COVID-19 Non-pharmaceutical …

Large clinical trials often generate complex and large datasets which need to be presented
frequently throughout the trial for interim analysis or to inform a data safety monitory board …

Background The literature includes many studies which individually assess the efficacy of
protective measures against the spread of the SARS-CoV-2 virus. This study considers the …

Introduction Currently, COVID-19 dominates the public health agenda and poses a
permanent threat, leading to health systems' exhaustion and unprecedented service …

Health care in the 21st century has started undergoing major changes due to the rising
number of patients with chronic conditions; increased access to new technologies, medical …

Abstract Purpose of Review Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the cause of coronavirus disease 2019 (COVID-19), continues to affect individuals …

Background This thematic scoping review of publications sought to understand the global
impact of COVID-19 on tuberculosis (TB), interpret the scope of resonating themes, and offer …